CNTA | tickerfilter.com

Fundamental analysis

Profitability 0%

Dept financing 0%

Liquidity 0%

Performance 10%

Performance

5 Days

5.06%

1 Month

27.24%

3 Months

66.26%

6 Months

29.31%

1 Year

90.41%

2 Year

226.88%

Key data

Stock price

$13.50

P/E Ratio

0.00

DAY RANGE

$12.93 - N/A

EPS

$0.00

52 WEEK RANGE

$5.15 - $14.48

52 WEEK CHANGE

$0.76

MARKET CAP

1.528 B

YIELD

N/A

SHARES OUTSTANDING

113.178 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/13/2024

BETA

1.51

PUBLIC FLOAT

AVERAGE 10 VOLUME

$468,376

AVERAGE 30 VOLUME

$417,563

Company detail

CEO:
Region: US
Website: centessa.com
Employees: 12
IPO year: -

Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

centessa pharmaceuticals plc is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. the company applies an asset-centric r&d model at scale to advance a portfolio of highly validated programs led by industry leading teams. each program is developed by a centessa subsidiary and supported by a centralized infrastructure and the centessa management team. the company is headquartered in cambridge, mass.

CNTA - Centessa Pharmaceuticals plc - ADR